Nicotinamide riboside (NR) is generally safe for healthy adults at commonly sold doses. The FDA accepted a GRAS (Generally Recognized as Safe) notice for NR in 2016, and the European Food Safety Authority has evaluated it for use in supplements at doses up to 300 mg per day. That said, side effects do occur in a meaningful minority of users, and one important situation calls for real caution: active cancer treatment.
What Side Effects to Expect
Most people tolerate NR without problems, but clinical trials have documented a range of side effects. A systematic review across 10 human studies found that the most commonly reported issues were muscle pain (24% of participants), nervous system complaints (22%), fatigue (20%), sleep disturbances (20%), and headaches (18%). Gastrointestinal issues showed up in about 9% of participants. More serious-sounding effects like cardiac symptoms (2%) and immune system reactions (1%) were rare.
These numbers come from studies where participants were taking NR for specific health conditions, so the rates may look higher than what a typical healthy supplement user would experience. Still, if you notice persistent muscle soreness, unusual tiredness, or disrupted sleep after starting NR, the supplement is a reasonable suspect.
How Much Is Considered Safe
The FDA’s accepted GRAS notice, filed by ChromaDex (the company behind the popular Niagen brand), set a conservative upper tolerable intake at 180 mg per day for someone weighing about 132 pounds. That number was calculated by taking the dose that caused no adverse effects in a 90-day animal study and dividing it by a 100-fold safety factor, a standard approach for translating animal data to human recommendations.
In Europe, the EFSA evaluated NR chloride for use in supplement capsules at up to 300 mg per day for healthy adults, including pregnant and lactating women. Many retail NR supplements sell doses of 250 to 300 mg, which falls within this European-assessed range but above the more conservative FDA-derived figure. Human trials have used doses ranging from 100 mg to 2,000 mg per day without triggering serious adverse events, though higher doses predictably produce more side effects. Animal toxicology studies pushed as high as 3,000 mg per kilogram of body weight and found that the resulting side effects resembled those of plain niacinamide (another form of vitamin B3) at similar doses.
The Cancer Concern Is Real but Specific
This is the safety issue that deserves the most attention. NR works by boosting levels of NAD+, a molecule every cell needs for energy and repair. In healthy tissue, that boost may offer benefits. But cancer cells use the same fuel. Research from Case Western Reserve University found that NAD+-boosting supplements shielded pancreatic cancer cells from three standard chemotherapy drugs in both lab experiments and mouse models.
The mechanism is straightforward: the supplements made tumors more resilient by increasing their energy supply, reduced the oxidative stress that chemotherapy relies on to kill cancer cells, and suppressed the DNA damage that triggers cancer cell death. In other words, NR can potentially undo what chemo is designed to do.
The researchers were careful to note that their findings do not suggest these supplements are dangerous for healthy people. The concern is specific to people with active cancer, particularly those undergoing chemotherapy. If you’re in cancer treatment, this is a conversation to have with your oncologist before taking any NAD+ precursor.
How NR Compares to NMN
NR and NMN (nicotinamide mononucleotide) are the two most popular NAD+ precursors on the supplement market, and their safety profiles overlap substantially. That’s because NMN is actually converted into NR outside the cell before being absorbed, then converted back to NMN inside the cell on its way to becoming NAD+. They essentially travel the same metabolic path, just boarding at different stops.
Toxicology data from regulatory filings shows both compounds have high no-observed-adverse-effect levels in animal studies. For NR, that level was 500 mg per kilogram of body weight per day in male rats and 1,200 mg/kg/day in female rats. For NMN, it was 1,500 mg/kg/day. Both compounds are noted for having fewer unfavorable side effects compared to other NAD+ precursors like nicotinic acid, which commonly causes flushing. From a safety standpoint, choosing between NR and NMN is less about which is safer and more about cost, availability, and regulatory status in your country.
Blood Pressure Medication Interaction
NR may lower blood pressure on its own. If you’re already taking medication for high blood pressure, combining it with NR could push your blood pressure too low. This is classified as a moderate interaction, meaning it’s not dangerous enough to rule out the combination entirely, but it does warrant monitoring. If you notice dizziness, lightheadedness, or unusual fatigue after adding NR to a blood pressure regimen, checking your readings more frequently is a practical first step.
Pregnancy and Breastfeeding
While the EFSA assessment included pregnant and lactating women in its evaluation of NR at up to 300 mg per day, direct clinical data in these populations is thin. A clinical trial (MOONRISE) has been investigating NR supplementation in lactating mothers of extremely preterm infants, looking at whether it supports milk production. But human testing with NR has largely been limited to general safety and bioavailability measures, and no large-scale trials in pregnant women have been completed. The lack of data isn’t evidence of harm, but it does mean the safety picture during pregnancy is incomplete.
What We Don’t Know Yet
The biggest gap in NR safety data is duration. Most human trials have run for weeks to a few months. There is no published long-term study tracking NR supplementation over years, which is exactly how most supplement users plan to take it. The short-term data is reassuring, with no serious adverse events in controlled settings, but whether decades of elevated NAD+ levels carry any hidden costs remains an open question. For a supplement marketed primarily as an anti-aging intervention, this is a notable blind spot.